Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #539258 on NorthWest Biotherapeutics Inc (NWBO)
hope4patients
11/27/22 6:17 AM
#539318 RE: Lykiri #539258
exwannabe
11/27/22 10:49 AM
#539366 RE: Lykiri #539258
Ex, Wrong!
Documenting the Endpoint Changes: Update the protocol in a formal protocol amendment. Not done until 9/23/20
v7.0, 23 September 2020 Final Protocol
Several changes to conform to the Statistical Analysis Plan (SAP), dated 23 September 2020 . Primary endpoint: OS for newly diagnosed glioblastoma patients, compared to external controls . Secondary endpoint: OS for recurrent glioblastoma patients, compared to external controls . SAP included as Appendix to the Protocol . The SAP v1.0 governs all analyses for the study